Reference
FDA. FDA Drug Safety Communication: FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients. Internet Document : 25 Feb 2015. Available from: URL: http://www.fda.gov/Drugs/DrugSafety/ucm435271.htm
Rights and permissions
About this article
Cite this article
Label warnings required to stop sharing of insulin pens. Reactions Weekly 1542, 5 (2015). https://doi.org/10.1007/s40278-015-8413-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-8413-y